Veterinary Medicines Information website

Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live

Product identification

Medicine name:
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDV Bio 11/A, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    5.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    6.60
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:
  • Glass Vial 50 x 1.0 Dose
  • Glass Vial 25 x 1.0 Dose
  • Glass Vial 10 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2376
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0124/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/03/2026
Download
Bulgarian (PDF)
Published on: 21/02/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/02/2022

Package Leaflet

English (PDF)
Published on: 14/03/2026
Download

Labelling

English (PDF)
Published on: 14/03/2026
Download

eu-puar-czv0124001-mr-biocan_novel_dhppi-en.pdf

English (PDF)
Published on: 14/03/2026
Download